Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Filgrastim (GCSF)

2 Open Trials

Trial Type Protocol No. &
Open Date
Summary

Supportive Care

VICCNCPED1210

02/20/2012

Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients with Dystrophic Epidermolysis Bullosa.

Treatment

VICCNCBMT12108

05/08/2013

A Non-Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched and HLA-Matched Bone Marrow for Patients with Sickle Cell Disease and Other Hemoglobinopathies